1 Reason I'm Never Selling Novo Nordisk Stock [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
(NYSE: NVO) stock as it has faced a number of challenges. It has been losing ground in the GLP-1 market, which accounts for most of its revenue. Novo Nordisk's 2026 guidance implies that its revenue will decline this year Despite the headwinds, there are many reasons to remain bullish on the company. Here's one reason why, as a shareholder, I intend to stay put. Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Experience matters Novo Nordisk has built a reputation over the past 100 years as a leader in the diabetes drug market. The company has made many breakthroughs and developed several generations of important drugs over this long period. This deep, long-standing expertise grants Novo Nordisk several advantages. First, massive internal data on clinical trial successes and failu
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- The Daily Chase: Energy prices surge as strikes on gulf facilities escalate [BNN Bloomberg (Canada)]BNN Bloomberg
- Novo Nordisk Targets Japan Self-Pay Market as Only 14,000 Access Obesity Drugs [Yahoo! Finance]Yahoo! Finance
- Lilly's next-gen obesity drug shows reduction in blood sugar levels in trial [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India [Yahoo! Finance]Yahoo! Finance
- Ozempic Is About to Go Generic in India, China and Canada [The New York Times]The New York Times
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/17/26 - Form 6-K
- 3/9/26 - Form 6-K
- 3/2/26 - Form 6-K
- NVO's page on the SEC website